With a government review of the NDIS now brought forward to 2022 and the new government promising to restore fairness and rebuild trust in the NDIS, there is reason for great optimism, and importantly, a golden opportunity to ensure the voice of the MS community is heard.
A new Australian study has shown that poor sleep is more common in people with MS and substantially affects quality of life, independent of other MS symptoms.
MS Australia has funded five new MS research projects totalling over $180,000 in the first round of incubator grants and postgraduate scholarships for 2022.
A new study has examined how the expansion of spaces inside the brain relates to damage in MS lesions and whole brain loss, towards personalised monitoring of changes in the brain.
Jodi has worked for many years as a passionate advocate for the MS community, pushing to ensure everyone with MS has fast access to the best possible treatments.
Lace up your trekking boots and soak in the extraordinary views of Ikara-Flinders Ranges National Park, as you travel with purpose through this ancient and spectacular landscape.
Today, the Federal Health and Aged Care Minister announced the listing of Vumerity® (diroximel fumarate) on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Australians living with relapsing remitting MS (RRMS).
National Pain Week (July 25 to 31) is an annual event coordinated by Chronic Pain Australia. Pain is one of the less recognised symptoms of multiple sclerosis but affects around two-thirds of the over 25,600 Australians living with the disease.
This year marks the 50th year of Multiple Sclerosis Australia, an organisation formed to drive awareness, research, and support for people with multiple sclerosis (MS).
